Recently announced Ontario Drug Benefit (ODB) program changes to reimbursement for high-strength long-acting opioids have elicited much discussion regarding their potential impact and implications in palliative care. The ODPRN conducted a rapid analysis to inform current discussions on the utilizations of high strength formulations of long-acting hydromorphone, morphine and fentanyl and their usage among palliative care patients. The analysis reports […]

Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!